Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03267316
Title	A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors (CANFOUR)
Acronym	CANFOUR
Recruitment	Completed
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Cantargia AB
Indications	lung squamous cell carcinoma lung non-squamous non-small cell carcinoma
Therapies	Nidanilimab Cisplatin + Gemcitabine + Nidanilimab Gemcitabine + Nab-paclitaxel + Nidanilimab
Age Groups:	adult \| senior
Covered Countries	SWE \| NOR \| NLD \| LVA \| LTU \| EST \| ESP \| DNK \| DEU \| BEL \| AUT